NEA Management Company LLC grew its position in shares of Tempus AI, Inc. (NASDAQ:TEM – Free Report) by 17.8% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,385,979 shares of the company’s stock after purchasing an additional 813,169 shares during the period. Tempus AI makes up 16.6% of NEA Management Company LLC’s portfolio, making the stock its 2nd biggest holding. NEA Management Company LLC’s holdings in Tempus AI were worth $304,846,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. First Horizon Advisors Inc. purchased a new position in shares of Tempus AI during the 3rd quarter valued at $30,000. Vestor Capital LLC purchased a new position in Tempus AI in the third quarter worth $153,000. Sandia Investment Management LP purchased a new position in Tempus AI in the second quarter worth $136,000. IQ EQ FUND MANAGEMENT IRELAND Ltd purchased a new position in Tempus AI in the third quarter worth $258,000. Finally, Clarus Group Inc. purchased a new position in Tempus AI in the third quarter worth $283,000.
Wall Street Analyst Weigh In
TEM has been the subject of several research reports. Bank of America lowered shares of Tempus AI from a “buy” rating to a “neutral” rating and upped their target price for the stock from $45.00 to $60.00 in a research report on Wednesday, October 2nd. Needham & Company LLC reiterated a “buy” rating and issued a $47.00 target price on shares of Tempus AI in a research report on Wednesday, August 7th. Piper Sandler reiterated a “neutral” rating and issued a $70.00 target price (up from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and upped their target price for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Finally, Loop Capital upped their price target on shares of Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research report on Tuesday, October 15th. Three equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $54.22.
Tempus AI Stock Performance
NASDAQ TEM opened at $62.59 on Friday. The company’s 50-day simple moving average is $53.15. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a 12-month low of $22.89 and a 12-month high of $79.49.
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Read More
- Five stocks we like better than Tempus AI
- Investing in Travel Stocks Benefits
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- Why Invest in 5G? How to Invest in 5G Stocks
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM – Free Report).
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.